SEQUENTA
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay. The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.
SEQUENTA
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.sequenta.com
Total Employee:
51+
Status:
Active
Contact:
650-243-3900
Email Addresses:
[email protected]
Total Funding:
43.46 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Amazon Oregon Region
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Celgene
Celgene investment in Venture Round - Sequenta
Index Ventures
Index Ventures investment in Series C - Sequenta
Foresite Capital
Foresite Capital investment in Series C - Sequenta
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series C - Sequenta
Index Ventures
Index Ventures investment in Venture Round - Sequenta
Farzad (Zod) Nazem
Farzad (Zod) Nazem investment in Venture Round - Sequenta
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Venture Round - Sequenta
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series B - Sequenta
Jacob Goldfield
Jacob Goldfield investment in Series B - Sequenta
Index Ventures
Index Ventures investment in Series B - Sequenta
Official Site Inspections
http://www.sequenta.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sequenta"
SEQUANTA
Sequanta Technologies is at the forefront of tumor immunity, cell and gene therapies and is committed to providing supportive services for pathogenesis study, target and biomarker …See details»
Sequenta - Crunchbase Company Profile & Funding
Organization. Sequenta . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Sequenta is …See details»
SEQUANTA
序祯达生物汇集行业内的顶级人才，核心研发团队由国内外著名学府毕业的分子生物学专家、生物信息学专家、免疫学专家等各领域专家组成，利用基因组学、转录组学、蛋白组学、微生物组 …See details»
Sequenta - Company Profile - Tracxn
Jan 11, 2025 Sequenta - Develops Immuno-sequencing products.. Raised a total funding of $43.5M over 5 rounds from 6 investors. Founded by Malek Faham and Thomas Willis in the year 2008. Sequenta has 832 competitors.See details»
Sequenta Company Profile 2024: Valuation, Investors
Sequenta General Information Description. Developer of clinical diagnostics based on a new platform for understanding immune system status. The …See details»
Sequenta - Products, Competitors, Financials, Employees, …
Headquarters Location. 400 E Jamie Court Suite 301. South San Francisco, California, 94080, United States. 888-552-8988See details»
SEQUANTA
基于序祯达生物实验室超高通量测序平台优势以及多组学检测分析服务经验，结合NovaSeq™ X Plus落地，我们将测序技术深入拓展到转录组、蛋白质组、微生物组等更多的组学研究，运用 …See details»
Sequanta Technologies Locations - Contract Research Map
240# Hedan Road, Waigaoqiao Free Trade Zone, Shanghai, China Shanghai, Shanghai, 200131 China Sequanta Technologies is a leading multi-omics research and clinical service provider in …See details»
Sequenta, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sequenta, LLC of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Sequenta Company Profile -Sales, Contacts, Competitors – Buzzfile
This organization primarily operates in the Diagnostic Substances business / industry within the Chemicals and Allied Products sector. This organization has been operating for approximately …See details»
Sequenta - Overview, News & Similar companies | ZoomInfo.com
Who is Sequenta. Sequenta is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical …See details»
Sequenta | VentureRadar
Molecular Imaging USA Privately Held Molecular Imaging, Inc. is a specialty contract research organization (CRO) located in Ann Arbor, Michigan. Molecular Imaging employs a wide array …See details»
SEQUANTA
Headquartered in the Waigaoqiao Bonded Area of China (Shanghai) Pilot Free Trade Zone, and equipped with a central laboratory spanning over 3000 m²See details»
Foundation Medicine Expands Partnership with Sequanta to …
Oct 21, 2023 About Sequanta Sequanta Technologies is a leading multi-omics research and clinical service provider in China, focusing on genomics, proteomics and related services to …See details»
Sequenta - Contacts, Employees, Board Members, Advisors
Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.See details»
Shanghai Xuzhenda Biotechnology Co. Ltd. - synapse.zhihuiya.com
We established a DNA reference material suite from four immortalized cell lines derived from a family of parents and monozygotic twins. Comprehensive reference datasets of 4.2 million …See details»
SEQUANTA
Sequanta Technologies provides high-throughput, high-sensitivity, and high-specificity protein detection services based on Olink proximity extension analysis technology, which can detect …See details»
Foundation Medicine Expands Partnership with Sequanta to …
Oct 21, 2023 Sequanta Technologies is a leading multi-omics research and clinical service provider in China, focusing on genomics, proteomics and related services to support …See details»
Sequanta Partners with Surging Single-Cell Genomics Startup to …
The global single-cell multi-omics market was valued at $2,458.80 million in 2020. It is expected to grow at a CAGR of 19.0% and reach $13,908.30 million by 2030. China, the world's second …See details»
Proteomics - SEQUANTA
Sequanta Technologies has successfully analyzed more than 20,000 samples using Olink technology. It has been honored with the Platinum badge, making it the sole service provider …See details»